Mitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice

Journal of the American Society of Hypertension

Volumn 5, Issue 3, 2011, Pages 154-160

  Choi, Hyehun ^a   Tostes, Rita C ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

ALDH2; Hypertension; ROS; vascular contraction

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDEHYDE DEHYDROGENASE ISOENZYME 2 RECOMBINANT PROTEIN; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CATALASE; DAIDZIN; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; HEART MUSCLE CONTRACTILITY; HYPERTENSION; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR RING;

ALDEHYDE DEHYDROGENASE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; CATALASE; CYCLIC N-OXIDES; ENZYME INHIBITORS; HYPERTENSION; ISOFLAVONES; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OXIDATIVE STRESS; PHENYLEPHRINE; REACTIVE OXYGEN SPECIES; SPIN LABELS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 79955592297     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2011.02.005     Document Type: Article

References (31)

1. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006;8(9-10):1865-79. (Pubitemid 44726359)
2. Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D, et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 2001;56:127-55.
3. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 1993;18(4):128-31. (Pubitemid 23105313)
4. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989;13(6 Pt 2):859-64. (Pubitemid 19157981)
5. Yang ZW, Zheng T, Wang J, Zhang A, Altura BT, Altura BM. Hydrogen peroxide induces contraction and raises [Ca2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 1999;360(6):646-53. (Pubitemid 30012464)
6. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 1998;125(6):1329-35. (Pubitemid 28542544)
7. Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 2004;287(4):H1495-500.
8. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97(8):1916-23.
9. Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999;34(4 Pt 2):943-9.
10. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998;32(1):59-64. (Pubitemid 28324125)
11. Wilson SK. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 1990;66(3):722-34.
12. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens 2001;19(4):741-8. (Pubitemid 32289554)
13. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13(4):305-14. (Pubitemid 19099600)
14. Fernandez-Alfonso MS, Ganten D, Paul M. Mechanisms of cardiac growth. The role of the renin-angiotensin system. Basic Res Cardiol 1992;87:173-81.
15. Lee MA, Bohm M, Paul M, Ganten D. Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation 1993;87(5 Suppl):IV7-13.
16. Paul M, Ganten D. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system. J Cardiovasc Pharmacol 1992;19(Suppl 5):S51-8.
17. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994;23(5):587-92.
18. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997;95(3):588-93.
19. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002;40(4):511-5.
20. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 2001;88(9):947-53. (Pubitemid 32441474)
21. Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2002;99(12):8306-11. (Pubitemid 34651048)
22. Szocs K, Lassegue B, Wenzel P, Wendt M, Daiber A, Oelze M, et al. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 2007;42(6):1111-8. (Pubitemid 46829198)
23. Wenzel P, Muller J, Zurmeyer S, Schuhmacher S, Schulz E, Oelze M, et al. ALDH-2 deficiency increases cardiovascular oxidative stress - evidence for indirect antioxidative properties. Biochem Biophys Res Commun 2008;367(1):137-43.
24. Giachini FR, Chiao CW, Carneiro FS, Lima VV, Carneiro ZN, Dorrance AM, et al. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction. Hypertension 2009;53(2):409-16.
25. Keung WM, Vallee BL. Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc Natl Acad Sci U S A 1993;90(4):1247-51. (Pubitemid 23058148)
26. DiFabio J, Ji Y, Vasiliou V, Thatcher GR, Bennett BM. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance. Mol Pharmacol 2003;64(5):1109-16. (Pubitemid 37314006)
27. Huellner MW, Schrepfer S, Weyand M, Weiner H, Wimplinger I, Eschenhagen T, et al. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins. FASEB J 2008;22(7):2561-8. (Pubitemid 351948673)
28. Yin G, Yan C, Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 2003;35(6):780-3. (Pubitemid 36379319)
29. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003;12(2):70-88. (Pubitemid 36700689)
30. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008; 102(4):488-96. (Pubitemid 351651106)
31. Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem 2003;84(5):1110-7. (Pubitemid 36330663)